Biocon shares fall 6% after Q2 net profit dives 84%. What should investors do?
Biopharmaceutical company Biocon’s shares fell 6% to Rs 320.80 in Thursday trade on the BSE after the firm reported a second-quarter loss, impacted by a deferred tax charge. The drugmaker’s net profit plunged 84.2% year-on-year (YoY) in Q2 to Rs 27.1 crore, sharply down from Rs 172 crore reported in the same quarter of the…
READ MORE